Sheeba K Thomas

13PUBLICATIONS
65CO-AUTHORS
Haematological tumoursMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular medicineApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 31, 2026
Phase I/II Trial of Evomela for Autologous Transplant in Myeloma: Schedule Optimization and Matched Comparison with MEL200.

|Jul 24, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

|Jul 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

|Jul 07, 2026
Single Cell Analysis of the Tumor Microenvironment Landscape Across the Disease Spectrum of Multiple Myeloma.

|Jul 06, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

|Apr 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

Pageof 3

Frequent Collaborators

7 joint publications

Robert Z Orlowski

7 joint publications

Krina K Patel

6 joint publications

Hans C Lee

6 joint publications

Oren Pasvolsky